Skip to main content

Research Repository

Advanced Search

All Outputs (1010)

OP02 Bridging the Gap: Reducing Delays in Axial Spondyloarthritis Diagnosis through Innovative Public Health Campaigning (2024)
Presentation / Conference
Eddison, J., Kennedy, N., Heron, N., Pendleton, A., & Webb, D. (2024, December). OP02 Bridging the Gap: Reducing Delays in Axial Spondyloarthritis Diagnosis through Innovative Public Health Campaigning. Presented at Celebrating the 10 Anniversary of the British Society for Spondyloarthritis

Background and aims
The Act on Axial SpA campaign is dedicated to minimising the lengthy 8.5-year delay in diagnosing axial spondyloarthritis (axial SpA) by implementing a pioneering Gold Standard diagnosis time of just one year. Collaborating with... Read More about OP02 Bridging the Gap: Reducing Delays in Axial Spondyloarthritis Diagnosis through Innovative Public Health Campaigning.

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide (2024)
Presentation / Conference
Beksac, M., Gonzalez Garcia, E., Delimpasi, S., Robak, P., Karunanithi, K., De Arriba, F., …Dimopoulos, M. A. (2024, December). Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide. Poster presented at 66th American Society of Hematology Annual Meeting, San Diego, California


Background

Use of triplet/quadruplet therapies for 1L multiple myeloma (MM) raises the need for novel combinations at first relapse. In the phase 3 DREAMM-8 (NCT04484623)... Read More about Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide.

Geko Venous Thromboembolism Prevention Study (2024)
Presentation / Conference
Sanyal, R., & Perros, I. (2024, December). Geko Venous Thromboembolism Prevention Study. Poster presented at 19th UK Stroke Forum Conference, Liverpool, Uk

Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform (2024)
Presentation / Conference
Russell, M., Massey, J., Roddy, E., MacKenna, B., Bacon, S., Goldacre, B., …Galloway, J. (2024, November). Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform. Poster presented at Abstract Supplement ACR Convergence 2024, Washington DC

Background/Purpose: Data from before the COVID-19 pandemic had shown persistently poor care for people with gout in many countries worldwide. Whether this was further exacerbated by the pandemic is not fully understood. Our objective was to investiga... Read More about Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform.

Dynamic Prediction of Cardiovascular Events in Incident Patients on Peritoneal Dialysis with Multivariate Joint Models Adjusting for Phosphate, Albumin, and Calcium Trajectories and Competing Risks (2024)
Presentation / Conference
Damgov, I., Kieser, M., Davies, S. J., Wong, M. G., Pollock, C. A., Johnson, D. W., & Schmitt, C. P. (2024, October). Dynamic Prediction of Cardiovascular Events in Incident Patients on Peritoneal Dialysis with Multivariate Joint Models Adjusting for Phosphate, Albumin, and Calcium Trajectories and Competing Risks. Poster presented at Kidney Week, San Diego, CA

629P Co-producing UK care quality standards in facioscapulohumeral muscular dystrophy (FSHD) in partnership with people with FSHD, carers and healthcare professionals: a qualitative focus group study (2024)
Presentation / Conference
Leone, E., Pandyan, A., Rogers, A., Kulshrestha, R., Hill, J., & Philp, F. (2024, October). 629P Co-producing UK care quality standards in facioscapulohumeral muscular dystrophy (FSHD) in partnership with people with FSHD, carers and healthcare professionals: a qualitative focus group study. Poster presented at Neuromuscular Disorders WMS Congress Issue - Abstracts 2024, Prague

O24 ACUTE KIDNEY INJURY IN PREGNANCY AND CARDIO-RENAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS (2024)
Presentation / Conference
Jeyaraman, D., Peiris, T. D. P., Alahmdi, H., Fish, R., Lambie, M., & Wu, P. (2024, September). O24 ACUTE KIDNEY INJURY IN PREGNANCY AND CARDIO-RENAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Presented at 30th Congress of the International Society of Hypertension, Cartegena de Indias, Colombia

Background and Objective: Acute kidney injury (AKI) is a common problem in pregnancy but adverse cardio-renal outcomes following AKI in pregnancy has not been systematically evaluated. We aimed to quantify the risk of adverse cardio-renal outcomes of... Read More about O24 ACUTE KIDNEY INJURY IN PREGNANCY AND CARDIO-RENAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS.

HPB SO43 - Meta-analysis of completion pancreatectomy for local recurrence of pancreatic cancer after the index pancreatectomy (2024)
Presentation / Conference
Evans, D., Hajibandeh, S., Hajibandeh, S., & Athwal, T. (2024, September). HPB SO43 - Meta-analysis of completion pancreatectomy for local recurrence of pancreatic cancer after the index pancreatectomy. Presented at 27th AUGIS Annual Scientifi c Meeting, Bridgewater Hall & Midland Hotel, Manchester

Background Poor prognosis post-resection of pancreatic cancer is owed to a high rates of cancer recurrence (approximately 80%) despite complete surgical resection being achieved. The role of surgical re-resection in patients with recurrent pancreatic... Read More about HPB SO43 - Meta-analysis of completion pancreatectomy for local recurrence of pancreatic cancer after the index pancreatectomy.